Glucagon-like peptide-1 receptor agonist use and violent crime among US adults.
The rapid proliferation of Glucagon-like peptide-1 (GLP-1) receptor agonists, marketed under brand names such as Ozempic and Wegovy, has already fundamentally altered the landscape of metabolic health and obesity treatment…
New Research Suggests Popular Weight-Loss and Diabetes Drugs May Be Linked to Reduced Violent Behavior
The burgeoning popularity of GLP-1 receptor agonists, medications like Ozempic and Wegovy, initially celebrated for their efficacy in weight management and diabetes control, is now the subject of novel scientific…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple







